Organizer

Summit Background

Growing at a CAGR of around 6%, the global pharmaceutical market is forecasted to reach US$ 1043.4 Billion by 2012. However, it is expected that the growth will slow down in near future due to patent expiration of key drugs and increased prevalence of generics. It is therefore more important than ever that pharma manufacturers should optimize their manufacturing line for cost reduction while following latest standards, like CGMP, QbD and PAT concepts etc.

A large untapped population and strong economic growth in major countries are expected to make Asia-Pacific the most lucrative pharmaceutical market in future. Growing by 20% per year. China is expected to be the third largest pharma market by 2013. However, the lack of manufacturing technologies and streamlined & consistent global supply network still are key hindrances for many local companies' development. To help national pharma manufacturers enter the global market, currently Chinese government is drafting new GMP standards which is expected to be released in this first half year. Making a thorough understanding of this vital policy and the pharma market itself is critical for doing successful business in China. more...

Summit Highlights

• Interpretation of the latest requirements & standards of pharma manufacturing
• Optimizing manufacturing planning to drive operation excellence
• Clarifying the significant contribution of engineering on pharma manufacturing
• Identifying how to develop an efficient and cost-effective supply chain management system
• Exploring the innovative solutions to optimize quality assurance systems
• Learning how to build the relationship between waste management and sustainable development
• Digging the real demand of Chinese pharma manufacturing market